Position in ABBV
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$2,176,937
+$1,945,311 QoQ
Shares Held
8,651
+712.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,898
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Proficio Capital Partners LLC holds $32,931,118 across 11 Drug Manufacturers - General names. ABBV ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,566 | $17,470,898 | |
| 2 | MRK |
Merck & Co., Inc.
|
36,360 | $4,672,260 | |
| 3 | JNJ |
Johnson & Johnson
|
10,547 | $2,678,621 | |
| 4 | AMGN |
Amgen Inc
|
6,520 | $2,361,022 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
8,651 | $2,176,937 | |
| 6 | AZN |
Astrazeneca PLC
|
7,518 | $1,425,563 | |
| 7 | BIIB |
Biogen Inc.
|
2,701 | $583,578 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,405 | $556,527 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,176,937 | 8,651 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $231,626 | 1,065 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $236,258 | 1,034 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $273,217 | 1,180 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,304,351 | 7,027 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,447,573 | 6,909 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,176,729 | 6,622 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $867,332 | 4,392 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,009,566 | 5,886 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,165,440 | 6,400 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $900,840 | 5,813 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $891,378 | 5,980 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $759,203 | 5,635 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,036,383 | 6,503 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $987,113 | 6,108 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $721,378 | 5,375 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $808,225 | 5,277 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $789,313 | 4,869 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $780,445 | 5,764 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $605,690 | 5,615 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $645,539 | 5,731 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $644,774 | 5,958 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $587,824 | 5,486 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $447,059 | 5,104 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $469,104 | 4,778 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $276,569 | 3,630 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||